This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Jerry Avorn, MD; Daniel E. Everitt, MD; Scott Weiss, MD, MS

JAMA. 1986;255(3):357-360.

Abstract
Little information exists on the epidemiology of central nervous system side effects in patients taking antihypertensive medications. We examined prevalence rates of tricyclic antidepressant (TCA) use among a random sample (N=143,253) of Medicaid recipients. The TCA use was compared for patients taking any of seven antihypertensive agents and for those prescribed insulin or oral hypoglycemic agents. Use of TCA was significantly higher in patients taking β-blockers (23% over two years) than for patients taking hydralazine or hypoglycemics (both 15%) or methyldopa or reserpine (both 10%). Prevalence rate ratios revealed a risk of being prescribed a TCA of 1.5 (95% confidence interval, 1.4 to 1.7) for patients receiving β-blockers relative to patients receiving hydralazine or hypoglycemics. β-Blocker use may be an important cause of iatrogenic depression among hypertensive patients.

(JAMA 1986;255:357-360)

Author Affiliations
From the Division on Aging (Drs Avorn and Everitt) and the Department of Social Medicine and Health Policy (Dr Avorn), Harvard Medical School; the Division of Gerontology (Dr Everitt) and the Joint Department of Medicine (Drs Everitt and Weiss), Beth Israel and Brigham and Women's Hospitals; the Geriatric Research Education and Clinical Center, West Roxbury/Brockton Veterans Administration Medical Center (Dr Everitt); and the Charles A. Dana Research Institute and the Harvard Thorndike Laboratory, Beth Israel Hospital (Dr Weiss); Boston.

Footnotes
Reprint requests to 643 Huntington Ave, Boston, MA 02115 (Dr Avorn).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Managing Drug-Risk Information -- What to Do with All Those New Numbers
Avorn and Schneeweiss
NEJM 2009;361:647-649.
FULL TEXT  

Incidence and Recurrence of Late-Life Depression
Luijendijk et al.
Arch Gen Psychiatry 2008;65:1394-1401.
ABSTRACT | FULL TEXT  

Beta-Blockers and Depression After Myocardial Infarction: A Multicenter Prospective Study
van Melle et al.
J Am Coll Cardiol 2006;48:2209-2214.
ABSTRACT | FULL TEXT  

{beta}-Blocker Therapy and Symptoms of Depression, Fatigue, and Sexual Dysfunction
Ko et al.
JAMA 2002;288:351-357.
ABSTRACT | FULL TEXT  

Trajectory of Psychological Risk and Incident Hypertension in Middle-Aged Women
Raikkonen et al.
Hypertension 2001;38:798-802.
ABSTRACT | FULL TEXT  

Effect of Pindolol on Onset of Action of Paroxetine in the Treatment of Major Depression: Intermediate Analysis of a Double-Blind, Placebo-Controlled Trial
Bordet et al.
Am. J. Psychiatry 1998;155:1346-1351.
ABSTRACT | FULL TEXT  

Self-rated health among cardiovascular drug users in a study of Swedish twins
Svardh et al.
Scand J Public Health 1998;26:223-231.
ABSTRACT  

Use of calcium channel blockers and risk of suicide: ecological findings confirmed in population based cohort study
Lindberg et al.
BMJ 1998;316:741-745.
ABSTRACT | FULL TEXT  

Psychopharmacological profile of the selective serotonin reuptake inhibitor, paroxetine: implication of noradrenergic and serotonergic mechanisms
Redrobe et al.
J Psychopharmacol 1998;12:348-355.
ABSTRACT  

A Molecular and Cellular Theory of Depression
Duman et al.
Arch Gen Psychiatry 1997;54:597-606.
ABSTRACT  

Pindolol, 5-Hydroxytryptamine, and Antidepressant Augmentation
Artigas
Arch Gen Psychiatry 1995;52:969-971.
ABSTRACT  

Trends in Medication Choices for Hypertension in the Elderly : The Decline of the Thiazides
Monane et al.
Hypertension 1995;25:1045-1051.
ABSTRACT | FULL TEXT  

Depression and 18-Month Prognosis After Myocardial Infarction
Frasure-Smith et al.
Circulation 1995;91:999-1005.
ABSTRACT | FULL TEXT  

Impact of the Treatment of Isolated Systolic Hypertension on Behavioral Variables: Results From the Systolic Hypertension in the Elderly Program
Applegate et al.
Arch Intern Med 1994;154:2154-2160.
ABSTRACT  

{beta}-Blockers and Depression: Evidence Against an Association
Bright and Everitt
JAMA 1992;267:1783-1787.
ABSTRACT  

{beta}-Blockers and Depression: The Clinician's Dilemma
Yudofsky
JAMA 1992;267:1826-1827.
ABSTRACT  

Can Physician Education Lower the Cost of Prescription Drugs? A Prospective, Controlled Trial
Frazier et al.
ANN INTERN MED 1991;115:116-121.
ABSTRACT  

The Ambiguous Relation between Aging and Adverse Drug Reactions
Gurwitz and Avorn
ANN INTERN MED 1991;114:956-966.
ABSTRACT  

Increased Prescribing of Antidepressants Subsequent to {beta}-Blocker Therapy
Thiessen et al.
Arch Intern Med 1990;150:2286-2290.
ABSTRACT  

Hypertension in Elderly Patients
Applegate
ANN INTERN MED 1989;110:901-915.
ABSTRACT  

Neuropsychological Side Effects of {beta}-Blockers
Dimsdale and Newton
Arch Intern Med 1989;149:514-525.
ABSTRACT  

Topical {beta}-Blocker Therapy and Central Nervous System Side Effects: A Preliminary Study Comparing Betaxolol and Timolol
Lynch et al.
Arch Ophthalmol 1988;106:908-911.
ABSTRACT  

The Effect of {beta}-Blockers on Mental Performance on Older Hypertensive Patients
Gengo et al.
Arch Intern Med 1988;148:779-784.
ABSTRACT  

Adverse Drug Reactions Associated with Global Cognitive Impairment in Elderly Persons
LARSON et al.
ANN INTERN MED 1987;107:169-173.
ABSTRACT  

Toxicity of Nonsteroidal Anti-inflammatory Drugs
Goodwin
Arch Intern Med 1987;147:34-35.
ABSTRACT  

Antidepressant Use in Patients Prescribed {beta}-Blockers
Scollins
JAMA 1986;255:3248-3248.
ABSTRACT  

Antidepressant Use in Patients Prescribed {beta}-Blockers
Stone
JAMA 1986;255:3248-3248.
ABSTRACT  

Antidepressant Use in Patients Prescribed {beta}-Blockers
Appel
JAMA 1986;255:3248-3248.
ABSTRACT  

Antidepressant Use in Patients Prescribed {beta}-Blockers
Mann
JAMA 1986;255:3248-3249.
ABSTRACT